Continuous Glucose Monitoring System Market Research Report Information by Product (Sensors, Transmitter & Receivers), by Application (Type 2 Diabetes, Type 1 Diabetes, Non-Diabetic Patients) by End user (Hospitals & Clinics, Homecare Settings, Others) and Region (North America, Europe, Asia-Pacific, and Rest of the World - Forecast till 2032

TABLE OF CONTENTS

1 MARKET INTRODUCTION

1.1 DEFINITION

1.2 SCOPE OF THE STUDY

1.3 RESEARCH OBJECTIVE

1.4 MARKET STRUCTURE

2 RESEARCH METHODOLOGY

2.1 OVERVIEW

2.2 DATA FLOW

2.2.1 DATA MINING PROCESS

2.3 PURCHASED DATABASE

2.4 SECONDARY SOURCES

2.4.1 SECONDARY RESEARCH DATA FLOW:

2.5 PRIMARY RESEARCH:

2.5.1 PRIMARY RESEARCH DATA FLOW:

2.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED

2.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE

2.6 APPROACHES FOR MARKET SIZE ESTIMATION:

2.6.1 REVENUE ANALYSIS APPROACH

2.7 DATA FORECASTING

2.7.1 DATA FORECASTING TECHNIQUE

2.8 DATA MODELING

2.8.1 MICROECONOMIC FACTOR ANALYSIS:

2.8.2 DATA MODELING:

2.9 TEAMS AND ANALYST CONTRIBUTION

3 MARKET DYNAMICS

3.1 INTRODUCTION

3.2 DRIVERS

3.2.1 INCREASING PREVALENCE OF DIABETES

3.2.2 RISING AWARENESS AMONG INDIVIDUALS ABOUT THE BENEFITS OF CONTINUOUS GLUCOSE MONITORING AND PATIENT EDUCATION

3.2.3 INCREASING GERIATRIC POPULATION

3.3 RESTRAINTS

3.3.1 HIGH COST OF CONTINUOUS GLUCOSE MONITORING SYSTEMS

3.4 OPPORTUNITY

3.4.1 GROWING TECHNOLOGICAL ADVANCEMENTS AND INNOVATION

4 MARKET FACTOR ANALYSIS

4.1 VALUE CHAIN ANALYSIS

4.1.1 R&D

4.1.2 MANUFACTURING

4.1.3 DISTRIBUTION AND SALES

4.1.4 POST-SALES MONITORING

4.2 PORTER’S FIVE FORCES MODEL

4.2.1 THREAT OF NEW ENTRANTS

4.2.2 BARGAINING POWER OF SUPPLIERS

4.2.3 THREAT OF SUBSTITUTES

4.2.4 BARGAINING POWER OF BUYERS

4.2.5 INTENSITY OF RIVALRY

4.3 IMPACT OF COVID-19 ON THE GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS

MARKET

4.3.1 OVERVIEW

5 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT

5.1 OVERVIEW

5.2 SENSORS

5.3 TRANSMITTER & RECEIVERS

6 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION

6.1 OVERVIEW

6.2 TYPE 2 DIABETES

6.3 TYPE 1 DIABETES

6.4 NON-DIABETIC PATIENTS

6.4.1 WEIGHT LOSS

6.4.2 DIET MANAGEMENT

6.4.3 HEALTH & WELLNESS

7 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER

7.1 OVERVIEW

7.2 HOSPITALS & CLINICS

7.3 HOMECARE SETTINGS

7.4 OTHERS

8 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION

8.1 GLOBAL

8.2 NORTH AMERICA

8.2.1 US

8.2.2 CANADA

8.3 EUROPE

8.3.1 GERMANY

8.3.2 FRANCE

8.3.3 UK

8.3.4 ITALY

8.3.5 SPAIN

8.3.6 REST OF EUROPE

8.4 ASIA-PACIFIC

8.4.1 CHINA

8.4.2 INDIA

8.4.3 JAPAN

8.4.4 SOUTH KOREA

8.4.5 AUSTRALIA

8.4.6 REST OF ASIA-PACIFIC

8.5 REST OF THE WORLD

8.5.1 MIDDLE EAST & AFRICA

8.5.2 LATIN AMERICA

9 COMPETITIVE LANDSCAPE

9.1 INTRODUCTION

9.2 MARKET SHARE ANALYSIS, 2023

9.3 COMPETITOR DASHBOARD

9.4 PUBLIC PLAYERS STOCK SUMMARY

9.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL

9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES

9.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL

9.6.2 AGREEMENT

9.6.3 PARTNERSHIP

9.6.4 COLLABORATION

10 COMPANY PROFILES

10.1 DEXCOM, INC

10.1.1 COMPANY OVERVIEW

10.1.2 FINANCIAL OVERVIEW

10.1.3 PRODUCTS OFFERED

10.1.4 KEY DEVELOPMENTS

10.1.5 SWOT ANALYSIS

10.1.6 KEY STRATEGIES

10.2 A. MENARINI DIAGNOSTICS SRL

10.2.1 COMPANY OVERVIEW

10.2.2 FINANCIAL OVERVIEW

10.2.3 PRODUCTS OFFERED

10.2.4 KEY DEVELOPMENTS

10.2.5 KEY STRATEGIES

10.3 SENSEONICS

10.3.1 COMPANY OVERVIEW

10.3.2 FINANCIAL OVERVIEW

10.3.3 PRODUCTS OFFERED

10.3.4 KEY DEVELOPMENTS

10.3.5 KEY STRATEGIES

10.4 MEDTRUM TECHNOLOGIES INC.

10.4.1 COMPANY OVERVIEW

10.4.2 FINANCIAL OVERVIEW

10.4.3 PRODUCTS OFFERED

10.4.4 KEY DEVELOPMENTS

10.4.5 KEY STRATEGIES

10.5 NEMAURA MEDICAL INC

10.5.1 COMPANY OVERVIEW

10.5.2 FINANCIAL OVERVIEW

10.5.3 PRODUCTS OFFERED

10.5.4 KEY DEVELOPMENTS

10.5.5 SWOT ANALYSIS

10.5.6 KEY STRATEGIES

10.6 ULTRAHUMAN HEALTHCARE PVT LTD

10.6.1 COMPANY OVERVIEW

10.6.2 FINANCIAL OVERVIEW

10.6.3 PRODUCTS OFFERED

10.6.4 KEY DEVELOPMENTS

10.6.5 KEY STRATEGIES

10.7 MEDTRONIC

10.7.1 COMPANY OVERVIEW

10.7.2 FINANCIAL OVERVIEW

10.7.3 PRODUCTS OFFERED

10.7.4 KEY DEVELOPMENTS

10.7.5 SWOT ANALYSIS

10.7.6 KEY STRATEGIES

10.8 ONE DROP

10.8.1 COMPANY OVERVIEW

10.8.2 FINANCIAL OVERVIEW

10.8.3 PRODUCTS OFFERED

10.8.4 KEY DEVELOPMENTS

10.8.5 SWOT ANALYSIS

10.8.6 KEY STRATEGIES

10.9 ABBOTT LABORATORIES, INC

10.9.1 COMPANY OVERVIEW

10.9.2 FINANCIAL OVERVIEW

10.9.3 PRODUCTS OFFERED

10.9.4 KEY DEVELOPMENTS

10.9.5 SWOT ANALYSIS

10.9.6 KEY STRATEGIES

10.10 SINOCARE

10.10.1 COMPANY OVERVIEW

10.10.2 FINANCIAL OVERVIEW

10.10.3 PRODUCTS OFFERED

10.10.4 KEY DEVELOPMENTS

10.10.5 KEY STRATEGIES

10.11 NUTRISENSE

10.11.1 COMPANY OVERVIEW

10.11.2 FINANCIAL OVERVIEW

10.11.3 PRODUCTS OFFERED

10.11.4 KEY DEVELOPMENTS

10.11.5 KEY STRATEGIES

10.12 SUPERSAPIENS

10.12.1 COMPANY OVERVIEW

10.12.2 FINANCIAL OVERVIEW

10.12.3 PRODUCTS OFFERED

10.12.4 KEY DEVELOPMENTS

10.12.5 KEY STRATEGIES

10.13 SIGNOS INC.

10.13.1 COMPANY OVERVIEW

10.13.2 FINANCIAL OVERVIEW

10.13.3 PRODUCTS OFFERED

10.13.4 KEY DEVELOPMENTS

10.13.5 KEY STRATEGIES

10.14 LEVELS

10.14.1 COMPANY OVERVIEW

10.14.2 FINANCIAL OVERVIEW

10.14.3 PRODUCTS OFFERED

10.14.4 KEY DEVELOPMENTS

10.14.5 KEY STRATEGIES

10.15 VERI

10.15.1 COMPANY OVERVIEW

10.15.2 FINANCIAL OVERVIEW

10.15.3 PRODUCTS OFFERED

10.15.4 KEY DEVELOPMENTS

10.15.5 KEY STRATEGIES

10.16 LUMEN

10.16.1 COMPANY OVERVIEW

10.16.2 FINANCIAL OVERVIEW

10.16.3 PRODUCTS OFFERED

10.16.4 KEY DEVELOPMENTS

10.16.5 KEY STRATEGIES

10.17 JANUARY.AI

10.17.1 COMPANY OVERVIEW

10.17.2 FINANCIAL OVERVIEW

10.17.3 PRODUCTS OFFERED

10.17.4 KEY DEVELOPMENTS

10.17.5 KEY STRATEGIES

11 DATA CITATIONS

LIST OF TABLES

TABLE 1 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD BILLION)

TABLE 2 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR SENSORS, BY REGION, 2019–2032 (USD BILLION)

TABLE 3 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR TRANSMITTER & RECEIVERS, BY REGION, 2019–2032 (USD BILLION)

TABLE 4 GLOBAL: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 5 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 2 DIABETES, BY REGION, 2019–2032 (USD BILLION)

TABLE 6 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 2 DIABETES, BY REGION, 2019–2032 (USD BILLION)

TABLE 7 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR NON-DIABETIC PATIENTS, BY REGION, 2019–2032 (USD BILLION)

TABLE 8 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 9 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR WEIGHT LOSS, BY REGION, 2019–2032 (USD BILLION)

TABLE 10 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR DIET MANAGEMENT, BY REGION, 2019–2032 (USD BILLION)

TABLE 11 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET HEALTH & WELLNESS, BY REGION, 2019–2032 (USD BILLION)

TABLE 12 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 13 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2019–2032 (USD BILLION)

TABLE 14 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR HOMECARE SETTINGS, BY REGION, 2019–2032 (USD BILLION)

TABLE 15 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR OTHERS, BY REGION, 2019–2032 (USD BILLION)

TABLE 16 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2019–2032 (USD BILLION)

TABLE 17 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2019–2032 (USD BILLION)

TABLE 18 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD BILLION)

TABLE 19 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 20 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 21 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 22 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD BILLION)

TABLE 23 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 24 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 25 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 26 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD BILLION)

TABLE 27 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 28 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 29 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 30 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2019–2032 (USD BILLION)

TABLE 31 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD BILLION)

TABLE 32 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 33 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 34 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 35 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD BILLION)

TABLE 36 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 37 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 38 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 39 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD BILLION)

TABLE 40 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 41 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 42 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 43 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD BILLION)

TABLE 44 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 45 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 46 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 47 ITALY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD BILLION)

TABLE 48 ITALY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 49 ITALY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 50 ITALY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 51 SPAIN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD BILLION)

TABLE 52 SPAIN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 53 SPAIN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 54 SPAIN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 55 REST OF EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD BILLION)

TABLE 56 REST OF EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 57 REST OF EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 58 REST OF EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 59 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2019–2032 (USD BILLION)

TABLE 60 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD BILLION)

TABLE 61 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 62 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 63 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019–2032 (USD BILLION)

TABLE 64 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD BILLION)

TABLE 65 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 66 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 67 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019–2032 (USD BILLION)

TABLE 68 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD BILLION)

TABLE 69 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 70 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 71 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019–2032 (USD BILLION)

TABLE 72 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD BILLION)

TABLE 73 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 74 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 75 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019–2032 (USD BILLION)

TABLE 76 SOUTH KOREA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD BILLION)

TABLE 77 SOUTH KOREA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 78 SOUTH KOREA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 79 SOUTH KOREA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019–2032 (USD BILLION)

TABLE 80 AUSTRALIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD BILLION)

TABLE 81 AUSTRALIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 82 AUSTRALIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 83 AUSTRALIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019–2032 (USD BILLION)

TABLE 84 REST OF ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD BILLION)

TABLE 85 REST OF ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 86 REST OF ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 87 REST OF ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019–2032 (USD BILLION)

TABLE 88 REST OT THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2019–2032 (USD BILLION)

TABLE 89 REST OF THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD BILLION)

TABLE 90 REST OF THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 91 REST OF THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 92 REST OF THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019–2032 (USD BILLION)

TABLE 93 MIDDLE EAST & AFRICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD BILLION)

TABLE 94 MIDDLE EAST & AFRICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 95 MIDDLE EAST & AFRICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 96 MIDDLE EAST & AFRICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019–2032 (USD BILLION)

TABLE 97 LATIN AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD BILLION)

TABLE 98 LATIN AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 99 LATIN AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 100 LATIN AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019–2032 (USD BILLION)

TABLE 101 PUBLIC PLAYERS STOCK SUMMARY

TABLE 102 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL

TABLE 103 PRODUCT LAUNCH/PRODUCT APPROVAL

TABLE 104 AGREEMENT

TABLE 105 PERTNERSHIP

TABLE 106 COLLABORATION

TABLE 107 DEXCOM, INC: PRODUCT OFFERED

TABLE 108 DEXCOM, INC: KEY DEVELOPMENTS

TABLE 109 A. MENARINI DIAGNOSTICS SRL: PRODUCT OFFERED

TABLE 110 A. MENARINI DIAGNOSTICS SRL: KEY DEVELOPMENTS

TABLE 111 SENSEONICS: PRODUCT OFFERED

TABLE 112 SENSEONICS: KEY DEVELOPMENTS

TABLE 113 MEDTRUM TECHNOLOGIES INC.: PRODUCTS OFFERED

TABLE 114 NEMAURA MEDICAL INC.: PRODUCTS OFFERED

TABLE 115 NEMAURA MEDICAL INC.: KEY DEVELOPMENTS

TABLE 116 ULTRAHUMAN HEALTHCARE PVT LTD.: PRODCUTS OFFERED

TABLE 117 MEDTRONIC: PRODUCTS OFFERED

TABLE 118 MEDTRONIC: KEY DEVELOPMENTS

TABLE 119 ONE DROP: PRODUCTS OFFERED

TABLE 120 ABBOTT LABORATORIES, INC.: PRODUCTS OFFERED

TABLE 121 ABBOTT LABORATORIES, INC.: KEY DEVELOPMENTS

TABLE 122 SINOCARE: PRODUCTS OFFERED

TABLE 123 NUTRISENSE: PRODUCTS OFFERED

TABLE 124 NEMAURA MEDICAL INC.: PRODUCTS OFFERED

TABLE 125 SIGNOS INC.: PRODUCTS OFFERED

TABLE 126 LEVELS: PRODUCTS OFFERED

TABLE 127 VERI: PRODUCTS OFFERED

TABLE 128 LUMEN: PRODUCTS OFFERED

TABLE 129 JANUARY.AI: PRODUCTS OFFERED

LIST OF FIGURES

FIGURE 1 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET: STRUCTURE

FIGURE 2 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET: GROWTH FACTOR ANALYSIS (2023-2032)

FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)

FIGURE 4 RESTRAINT IMPACT ANALYSIS (2023-2032)

FIGURE 5 VALUE CHAIN ANALYSIS OF THE GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET

FIGURE 6 PORTER’S FIVE FORCES ANALYSIS: GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET

FIGURE 7 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2023 & 2032 (USD MILLION)

FIGURE 8 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, SHARE (%), BY PRODUCT, 2023

FIGURE 9 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2023 & 2032 (USD MILLION)

FIGURE 10 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, SHARE (%), BY APPLICATION, 2023

FIGURE 11 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2023 & 2032 (USD MILLION)

FIGURE 12 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, SHARE (%), BY END USER, 2023

FIGURE 13 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY REGION, 2023 (% SHARE)

FIGURE 14 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2023 & 2032 (USD MILLION)

FIGURE 15 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)

FIGURE 16 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)

FIGURE 17 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)

FIGURE 18 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)

FIGURE 19 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)

FIGURE 20 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE (%), BY COUNTRY, 2023

FIGURE 21 REST OT THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2023 & 2032 (USD MILLION)

FIGURE 22 REST OT THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE (%), BY REGION, 2023

FIGURE 23 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET PLAYERS: COMPETITIVE ANALSIS, 2023

FIGURE 24 COMPETITOR DASHBOARD: GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET

FIGURE 25 DEXCOM, INC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 26 DEXCOM, INC: SWOT ANALYSIS

FIGURE 27 SENSEONICS: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 28 NEMAURA MEDICAL INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 29 NEMAURA MEDICAL INC.: SWOT ANALYSIS

FIGURE 30 MEDTRONIC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 31 MEDTRONIC: SWOT ANALYSIS

FIGURE 32 ONE DROP: SWOT ANALYSIS

FIGURE 33 ABBOTT LABORATORIES, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 34 ABBOTT LABORATORIES INC.: SWOT ANALYSIS